A survey to overview the presence of pollen supplements and substitutes for bees and other animal species in the EU was conducted to serve as input for the regulatory risk assessment of genetically modified feed by the EFSA GMO Panel. A comprehensive mapp ...
A retrospective cumulative risk assessment of dietary exposure to pesticide residues was conducted for chronic inhibition of acetylcholinesterase. The pesticides considered in this assessment were identified and characterised in a previous scientific repo ...
Clear guidance on conducting Environmental Risk Assessment (ERA) of nanomaterials is becoming more and more relevant as new applications of nanomaterials in the food and feed chain are developed. Upon request from EFSA, this report compiles and structures ...
In this project we set up a human cell‐based DNT in vitro testing strategy that is based on test methods with high readiness and data generated therefrom. The methods underwent afit‐for‐purpose evaluation that considered four key elements: 1. The test sys ...
This report is the outcome of an EFSA procurement (NP/EFSA/GMO/2018/01) reviewing relevant scientific information on in silico prediction methods for protein toxicity, that could support the food and feed risk assessment. Several proteins are associated w ...
This report describes the tasks performed in the period 6/12/2019 to 16/07/2020under the EFSA contract OC/EFSA/GMO/2018/02, Lot 2 on toxicological studies and animal feeding studies included in applicationsfor market authorisation of genetically modified ...
The European Commission asked EFSA to undertake a ‘repair action’ of the FOCUS surface water report after the EFSA Pesticide Steering Network had been consulted. The main request was to introduce into all FOCUS surface water scenarios (both run‐off and dr ...
The Mixed‐lineage leukemia (MLL) gene constitutes a genomic hotspot commonly rearranged/translocated in human acute leukemia (AL). MLL rearrangements (MLL r) represent a common hallmark of both de novo AL and therapy‐related acute myeloid leukemia (t‐AML) ...
This report describes the tasks performed in the period 28/11/2018 to 5/12/2019under the EFSA contract OC/EFSA/GMO/2018/02, Lot 2 on toxicological studies and animal feeding studies included in applicationsfor market authorisation of genetically modified ...
To harmonise vertebrate OECD Test Guidelines for endocrine disruption testing between mammalian and non‐mammalian test species, additional Estrogen, Androgen, Thyroid and Steroidogenesis (EATS) modality endpoints in non‐mammalian models need to be assesse ...